Li, Zihai
Article History
Received: 17 April 2019
Accepted: 17 April 2019
First Online: 3 May 2019
Compliance with ethical standards
:
: ZL’s work has been funded by the NIH, and has a sponsored research agreement with Bristol-Myers Squibb to develop GARP-targeted immunotherapeutics against cancer.